Dataset ID
NHA000161
- Type of data
- GWAS for Alzheimer's disease
- Access criteria
- Unrestricted-access
- Total data volume
- 142 MB
- File formats
- DOCX
- ZIP
- Research
- hum0237
- Date published
- 2021-03-05
- Date modified
- 2021-03-05
- Secondary ID
- hum0237.v1.gwas.v1
Unrestricted-access files linked to this dataset
| File | Label | Size | Copy URL |
|---|---|---|---|
| Dictionary_ | Dictionary file | 19.7 KB | |
| hum0237_ | 142 MB |
Analysis method
Genotyping by array
- Materials and participants
- Alzheimer's disease (ICD10: F00): 3,962 cases
4,074 controls - Health statusMixed
- Subject count8036 (Individual)
- Disease
- Alzheimer's disease (F00)
- Sample description
- DNAs extracted from peripheral blood cells
- TissuePeripheral blood
- Tumor / normalNormal
- Sample provider
- N/A
- Experimental method
- Genotyping by array
- Target
- N/A
- Reagent kit
- Axiom 2.0 Reagent Kit
- Platform
- Affymetrix Genome-Wide Human SNP Array 6.0
Affymetrix Japonica Array - QC and filtering
- Sample QCs: (1) sex inconsistencies (--check-sex), (2) inbreeding coefficient (--het 0.1), (3) genotype missingness (--missing 0.05), (4) kinship coefficient (--genome 0.2) and (5) exclusion of outliers from the clusters of East Asian populations in principal component analysis that was conducted together with 1000 Genomes Phase 3 data.
Marker (SNPs and Indels) QCs: (1) genotyping efficiency or call rate (--geno 0.95), (2) minor allele frequency (--freq 0.001), (3) Hardy-Weinberg equilibrium (--hwe 0.001). - Imputation
- IMPUTE2 with 3.5K Japanese reference panel
IMPUTE2 with 1000 Genomes Project reference panel (1000 Genomes Phase 3) - Analysis method
- Axiom Analysis suite 1.1.1.66
- Variant count
- 4,852,957 SNVs
- Processed data type
- GWAS summary statistics
- Data use policy
- NBDC data sharing policy (JGAP000001)